Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Recombinant Human Glial Maturation Factor Beta (GMFb) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Global Recombinant Human Glial Maturation Factor Beta (GMFb) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Industry: Medical Devices & Consumables
Published Date: 2025-05-10
Pages: 108 Pages
Report ld: 4734226
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Recombinant Human Glial Maturation Factor Beta (GMFb) Market Size(US$)
CAGR 2025-2031
6.5%
Market Size,2031
USD 159
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 109 million
Market Forecast in 2031(Value)
US$ 159 million
CAGR
6.5%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Recombinant Human Glial Maturation Factor Beta (GMFb) market size was US$ 104 million in 2024 and is forecast to a readjusted size of US$ 159 million by 2031 with a CAGR of 6.5% during the forecast period 2025-2031.
By 2025, the evolving U.S. tariff policy is poised to inject considerable uncertainty into the global economic landscape. This report delves into the latest U.S. tariff measures and the corresponding policy responses across the globe, evaluating their impacts on Recombinant Human Glial Maturation Factor Beta (GMFb) market competitiveness, regional economic performance, and supply chain configurations.
GMF-beta belongs to the actin-binding ADF/cofilin family of proteins. It contains an ADF-H domain, but crystallographic and NMR studies have shown structural differences between the human and mouse ADF-H domains. It was originally identified as a growth gamma differentiation factor acting on neurons and glial cells. It has also been shown to function intracellularly as a regulator of MAP kinase signaling.
The North America Recombinant Human Glial Maturation Factor Beta (GMFb) market size was US$ million in 2024, while Europe was US$ million. The proportion of the North America was % in 2024, while Europe percentage was %, and it is predicted that Europe share will reach % in 2031, trailing a CAGR of % through the analysis period.
The global key manufacturers of Recombinant Human Glial Maturation Factor Beta (GMFb) include Thermo Fisher Scientific Inc., Bio-Techne, Scientists Helping Scientists, Abcam Limited, FUJIFILM Irvine Scientific, BD Biosciences, Bio-Rad Laboratories, Inc., BPS Bioscience, Inc., Elabscience, Yisheng Biotechnology (Shanghai) Co., Ltd., etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.
In North America, in terms of sales volume, in 2024, the top three players hold a share about %, while in Europe, top three players hold a share nearly %.
The global Recombinant Human Glial Maturation Factor Beta (GMFb) market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
MARKET SEGMENTATION
By Company
- Thermo Fisher Scientific Inc.
- Bio-Techne
- Scientists Helping Scientists
- Abcam Limited
- FUJIFILM Irvine Scientific
- BD Biosciences
- Bio-Rad Laboratories, Inc.
- BPS Bioscience, Inc.
- Elabscience
- Yisheng Biotechnology (Shanghai) Co., Ltd.
- Abbkine
- Beijing Biocreative Technology Co., Ltd.
- Shanghai Yaji Biotechnology Co., Ltd.
- Cellverse Co., Ltd.
- Dalian Meilun Biotech Co., Ltd.
- Sino Biological,Inc.
- Prospec-Tany Technogene Ltd
- ENZO
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Purity＜95%
- Purity ≥95%
Segment by Application
- University
- Research Center
CHAPTER OUTLINE
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Recombinant Human Glial Maturation Factor Beta (GMFb) market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Purity ≥95% in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Research Center in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Recombinant Human Glial Maturation Factor Beta (GMFb) value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Recombinant Human Glial Maturation Factor Beta (GMFb) Product Scope
1.2 Recombinant Human Glial Maturation Factor Beta (GMFb) by Type
1.2.1 Global Recombinant Human Glial Maturation Factor Beta (GMFb) Sales by Type (2020 & 2024 & 2031)
1.2.2 Purity＜95%
1.2.3 Purity ≥95%
1.3 Recombinant Human Glial Maturation Factor Beta (GMFb) by Application
1.3.1 Global Recombinant Human Glial Maturation Factor Beta (GMFb) Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 University
1.3.3 Research Center
1.4 Global Recombinant Human Glial Maturation Factor Beta (GMFb) Market Estimates and Forecasts (2020-2031)
1.4.1 Global Recombinant Human Glial Maturation Factor Beta (GMFb) Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Recombinant Human Glial Maturation Factor Beta (GMFb) Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Recombinant Human Glial Maturation Factor Beta (GMFb) Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Recombinant Human Glial Maturation Factor Beta (GMFb) Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Recombinant Human Glial Maturation Factor Beta (GMFb) Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Recombinant Human Glial Maturation Factor Beta (GMFb) Sales Market Share by Region (2020-2025)
2.2.2 Global Recombinant Human Glial Maturation Factor Beta (GMFb) Revenue Market Share by Region (2020-2025)
2.3 Global Recombinant Human Glial Maturation Factor Beta (GMFb) Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Recombinant Human Glial Maturation Factor Beta (GMFb) Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Recombinant Human Glial Maturation Factor Beta (GMFb) Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Recombinant Human Glial Maturation Factor Beta (GMFb) Market Size and Prospective (2020-2031)
2.4.2 Europe Recombinant Human Glial Maturation Factor Beta (GMFb) Market Size and Prospective (2020-2031)
2.4.3 China Recombinant Human Glial Maturation Factor Beta (GMFb) Market Size and Prospective (2020-2031)
2.4.4 Japan Recombinant Human Glial Maturation Factor Beta (GMFb) Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Recombinant Human Glial Maturation Factor Beta (GMFb) Historic Market Review by Type (2020-2025)
3.1.1 Global Recombinant Human Glial Maturation Factor Beta (GMFb) Sales by Type (2020-2025)
3.1.2 Global Recombinant Human Glial Maturation Factor Beta (GMFb) Revenue by Type (2020-2025)
3.1.3 Global Recombinant Human Glial Maturation Factor Beta (GMFb) Price by Type (2020-2025)
3.2 Global Recombinant Human Glial Maturation Factor Beta (GMFb) Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Recombinant Human Glial Maturation Factor Beta (GMFb) Sales Forecast by Type (2026-2031)
3.2.2 Global Recombinant Human Glial Maturation Factor Beta (GMFb) Revenue Forecast by Type (2026-2031)
3.2.3 Global Recombinant Human Glial Maturation Factor Beta (GMFb) Price Forecast by Type (2026-2031)
3.3 Different Types Recombinant Human Glial Maturation Factor Beta (GMFb) Representative Players
4 Global Market Size by Application
4.1 Global Recombinant Human Glial Maturation Factor Beta (GMFb) Historic Market Review by Application (2020-2025)
4.1.1 Global Recombinant Human Glial Maturation Factor Beta (GMFb) Sales by Application (2020-2025)
4.1.2 Global Recombinant Human Glial Maturation Factor Beta (GMFb) Revenue by Application (2020-2025)
4.1.3 Global Recombinant Human Glial Maturation Factor Beta (GMFb) Price by Application (2020-2025)
4.2 Global Recombinant Human Glial Maturation Factor Beta (GMFb) Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Recombinant Human Glial Maturation Factor Beta (GMFb) Sales Forecast by Application (2026-2031)
4.2.2 Global Recombinant Human Glial Maturation Factor Beta (GMFb) Revenue Forecast by Application (2026-2031)
4.2.3 Global Recombinant Human Glial Maturation Factor Beta (GMFb) Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Recombinant Human Glial Maturation Factor Beta (GMFb) Application
5 Competition Landscape by Players
5.1 Global Recombinant Human Glial Maturation Factor Beta (GMFb) Sales by Players (2020-2025)
5.2 Global Top Recombinant Human Glial Maturation Factor Beta (GMFb) Players by Revenue (2020-2025)
5.3 Global Recombinant Human Glial Maturation Factor Beta (GMFb) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human Glial Maturation Factor Beta (GMFb) as of 2024)
5.4 Global Recombinant Human Glial Maturation Factor Beta (GMFb) Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Recombinant Human Glial Maturation Factor Beta (GMFb), Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Recombinant Human Glial Maturation Factor Beta (GMFb), Product Type & Application
5.7 Global Key Manufacturers of Recombinant Human Glial Maturation Factor Beta (GMFb), Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Recombinant Human Glial Maturation Factor Beta (GMFb) Sales by Company
6.1.1.1 North America Recombinant Human Glial Maturation Factor Beta (GMFb) Sales by Company (2020-2025)
6.1.1.2 North America Recombinant Human Glial Maturation Factor Beta (GMFb) Revenue by Company (2020-2025)
6.1.2 North America Recombinant Human Glial Maturation Factor Beta (GMFb) Sales Breakdown by Type (2020-2025)
6.1.3 North America Recombinant Human Glial Maturation Factor Beta (GMFb) Sales Breakdown by Application (2020-2025)
6.1.4 North America Recombinant Human Glial Maturation Factor Beta (GMFb) Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Recombinant Human Glial Maturation Factor Beta (GMFb) Sales by Company
6.2.1.1 Europe Recombinant Human Glial Maturation Factor Beta (GMFb) Sales by Company (2020-2025)
6.2.1.2 Europe Recombinant Human Glial Maturation Factor Beta (GMFb) Revenue by Company (2020-2025)
6.2.2 Europe Recombinant Human Glial Maturation Factor Beta (GMFb) Sales Breakdown by Type (2020-2025)
6.2.3 Europe Recombinant Human Glial Maturation Factor Beta (GMFb) Sales Breakdown by Application (2020-2025)
6.2.4 Europe Recombinant Human Glial Maturation Factor Beta (GMFb) Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Recombinant Human Glial Maturation Factor Beta (GMFb) Sales by Company
6.3.1.1 China Recombinant Human Glial Maturation Factor Beta (GMFb) Sales by Company (2020-2025)
6.3.1.2 China Recombinant Human Glial Maturation Factor Beta (GMFb) Revenue by Company (2020-2025)
6.3.2 China Recombinant Human Glial Maturation Factor Beta (GMFb) Sales Breakdown by Type (2020-2025)
6.3.3 China Recombinant Human Glial Maturation Factor Beta (GMFb) Sales Breakdown by Application (2020-2025)
6.3.4 China Recombinant Human Glial Maturation Factor Beta (GMFb) Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Recombinant Human Glial Maturation Factor Beta (GMFb) Sales by Company
6.4.1.1 Japan Recombinant Human Glial Maturation Factor Beta (GMFb) Sales by Company (2020-2025)
6.4.1.2 Japan Recombinant Human Glial Maturation Factor Beta (GMFb) Revenue by Company (2020-2025)
6.4.2 Japan Recombinant Human Glial Maturation Factor Beta (GMFb) Sales Breakdown by Type (2020-2025)
6.4.3 Japan Recombinant Human Glial Maturation Factor Beta (GMFb) Sales Breakdown by Application (2020-2025)
6.4.4 Japan Recombinant Human Glial Maturation Factor Beta (GMFb) Major Customer
6.4.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Thermo Fisher Scientific Inc.
7.1.1 Thermo Fisher Scientific Inc. Company Information
7.1.2 Thermo Fisher Scientific Inc. Business Overview
7.1.3 Thermo Fisher Scientific Inc. Recombinant Human Glial Maturation Factor Beta (GMFb) Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Thermo Fisher Scientific Inc. Recombinant Human Glial Maturation Factor Beta (GMFb) Products Offered
7.1.5 Thermo Fisher Scientific Inc. Recent Development
7.2 Bio-Techne
7.2.1 Bio-Techne Company Information
7.2.2 Bio-Techne Business Overview
7.2.3 Bio-Techne Recombinant Human Glial Maturation Factor Beta (GMFb) Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Bio-Techne Recombinant Human Glial Maturation Factor Beta (GMFb) Products Offered
7.2.5 Bio-Techne Recent Development
7.3 Scientists Helping Scientists
7.3.1 Scientists Helping Scientists Company Information
7.3.2 Scientists Helping Scientists Business Overview
7.3.3 Scientists Helping Scientists Recombinant Human Glial Maturation Factor Beta (GMFb) Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Scientists Helping Scientists Recombinant Human Glial Maturation Factor Beta (GMFb) Products Offered
7.3.5 Scientists Helping Scientists Recent Development
7.4 Abcam Limited
7.4.1 Abcam Limited Company Information
7.4.2 Abcam Limited Business Overview
7.4.3 Abcam Limited Recombinant Human Glial Maturation Factor Beta (GMFb) Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Abcam Limited Recombinant Human Glial Maturation Factor Beta (GMFb) Products Offered
7.4.5 Abcam Limited Recent Development
7.5 FUJIFILM Irvine Scientific
7.5.1 FUJIFILM Irvine Scientific Company Information
7.5.2 FUJIFILM Irvine Scientific Business Overview
7.5.3 FUJIFILM Irvine Scientific Recombinant Human Glial Maturation Factor Beta (GMFb) Sales, Revenue and Gross Margin (2020-2025)
7.5.4 FUJIFILM Irvine Scientific Recombinant Human Glial Maturation Factor Beta (GMFb) Products Offered
7.5.5 FUJIFILM Irvine Scientific Recent Development
7.6 BD Biosciences
7.6.1 BD Biosciences Company Information
7.6.2 BD Biosciences Business Overview
7.6.3 BD Biosciences Recombinant Human Glial Maturation Factor Beta (GMFb) Sales, Revenue and Gross Margin (2020-2025)
7.6.4 BD Biosciences Recombinant Human Glial Maturation Factor Beta (GMFb) Products Offered
7.6.5 BD Biosciences Recent Development
7.7 Bio-Rad Laboratories, Inc.
7.7.1 Bio-Rad Laboratories, Inc. Company Information
7.7.2 Bio-Rad Laboratories, Inc. Business Overview
7.7.3 Bio-Rad Laboratories, Inc. Recombinant Human Glial Maturation Factor Beta (GMFb) Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Bio-Rad Laboratories, Inc. Recombinant Human Glial Maturation Factor Beta (GMFb) Products Offered
7.7.5 Bio-Rad Laboratories, Inc. Recent Development
7.8 BPS Bioscience, Inc.
7.8.1 BPS Bioscience, Inc. Company Information
7.8.2 BPS Bioscience, Inc. Business Overview
7.8.3 BPS Bioscience, Inc. Recombinant Human Glial Maturation Factor Beta (GMFb) Sales, Revenue and Gross Margin (2020-2025)
7.8.4 BPS Bioscience, Inc. Recombinant Human Glial Maturation Factor Beta (GMFb) Products Offered
7.8.5 BPS Bioscience, Inc. Recent Development
7.9 Elabscience
7.9.1 Elabscience Company Information
7.9.2 Elabscience Business Overview
7.9.3 Elabscience Recombinant Human Glial Maturation Factor Beta (GMFb) Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Elabscience Recombinant Human Glial Maturation Factor Beta (GMFb) Products Offered
7.9.5 Elabscience Recent Development
7.10 Yisheng Biotechnology (Shanghai) Co., Ltd.
7.10.1 Yisheng Biotechnology (Shanghai) Co., Ltd. Company Information
7.10.2 Yisheng Biotechnology (Shanghai) Co., Ltd. Business Overview
7.10.3 Yisheng Biotechnology (Shanghai) Co., Ltd. Recombinant Human Glial Maturation Factor Beta (GMFb) Sales, Revenue and Gross Margin (2020-2025)
7.10.4 Yisheng Biotechnology (Shanghai) Co., Ltd. Recombinant Human Glial Maturation Factor Beta (GMFb) Products Offered
7.10.5 Yisheng Biotechnology (Shanghai) Co., Ltd. Recent Development
7.11 Abbkine
7.11.1 Abbkine Company Information
7.11.2 Abbkine Business Overview
7.11.3 Abbkine Recombinant Human Glial Maturation Factor Beta (GMFb) Sales, Revenue and Gross Margin (2020-2025)
7.11.4 Abbkine Recombinant Human Glial Maturation Factor Beta (GMFb) Products Offered
7.11.5 Abbkine Recent Development
7.12 Beijing Biocreative Technology Co., Ltd.
7.12.1 Beijing Biocreative Technology Co., Ltd. Company Information
7.12.2 Beijing Biocreative Technology Co., Ltd. Business Overview
7.12.3 Beijing Biocreative Technology Co., Ltd. Recombinant Human Glial Maturation Factor Beta (GMFb) Sales, Revenue and Gross Margin (2020-2025)
7.12.4 Beijing Biocreative Technology Co., Ltd. Recombinant Human Glial Maturation Factor Beta (GMFb) Products Offered
7.12.5 Beijing Biocreative Technology Co., Ltd. Recent Development
7.13 Shanghai Yaji Biotechnology Co., Ltd.
7.13.1 Shanghai Yaji Biotechnology Co., Ltd. Company Information
7.13.2 Shanghai Yaji Biotechnology Co., Ltd. Business Overview
7.13.3 Shanghai Yaji Biotechnology Co., Ltd. Recombinant Human Glial Maturation Factor Beta (GMFb) Sales, Revenue and Gross Margin (2020-2025)
7.13.4 Shanghai Yaji Biotechnology Co., Ltd. Recombinant Human Glial Maturation Factor Beta (GMFb) Products Offered
7.13.5 Shanghai Yaji Biotechnology Co., Ltd. Recent Development
7.14 Cellverse Co., Ltd.
7.14.1 Cellverse Co., Ltd. Company Information
7.14.2 Cellverse Co., Ltd. Business Overview
7.14.3 Cellverse Co., Ltd. Recombinant Human Glial Maturation Factor Beta (GMFb) Sales, Revenue and Gross Margin (2020-2025)
7.14.4 Cellverse Co., Ltd. Recombinant Human Glial Maturation Factor Beta (GMFb) Products Offered
7.14.5 Cellverse Co., Ltd. Recent Development
7.15 Dalian Meilun Biotech Co., Ltd.
7.15.1 Dalian Meilun Biotech Co., Ltd. Company Information
7.15.2 Dalian Meilun Biotech Co., Ltd. Business Overview
7.15.3 Dalian Meilun Biotech Co., Ltd. Recombinant Human Glial Maturation Factor Beta (GMFb) Sales, Revenue and Gross Margin (2020-2025)
7.15.4 Dalian Meilun Biotech Co., Ltd. Recombinant Human Glial Maturation Factor Beta (GMFb) Products Offered
7.15.5 Dalian Meilun Biotech Co., Ltd. Recent Development
7.16 Sino Biological,Inc.
7.16.1 Sino Biological,Inc. Company Information
7.16.2 Sino Biological,Inc. Business Overview
7.16.3 Sino Biological,Inc. Recombinant Human Glial Maturation Factor Beta (GMFb) Sales, Revenue and Gross Margin (2020-2025)
7.16.4 Sino Biological,Inc. Recombinant Human Glial Maturation Factor Beta (GMFb) Products Offered
7.16.5 Sino Biological,Inc. Recent Development
7.17 Prospec-Tany Technogene Ltd
7.17.1 Prospec-Tany Technogene Ltd Company Information
7.17.2 Prospec-Tany Technogene Ltd Business Overview
7.17.3 Prospec-Tany Technogene Ltd Recombinant Human Glial Maturation Factor Beta (GMFb) Sales, Revenue and Gross Margin (2020-2025)
7.17.4 Prospec-Tany Technogene Ltd Recombinant Human Glial Maturation Factor Beta (GMFb) Products Offered
7.17.5 Prospec-Tany Technogene Ltd Recent Development
7.18 ENZO
7.18.1 ENZO Company Information
7.18.2 ENZO Business Overview
7.18.3 ENZO Recombinant Human Glial Maturation Factor Beta (GMFb) Sales, Revenue and Gross Margin (2020-2025)
7.18.4 ENZO Recombinant Human Glial Maturation Factor Beta (GMFb) Products Offered
7.18.5 ENZO Recent Development
8 Recombinant Human Glial Maturation Factor Beta (GMFb) Manufacturing Cost Analysis
8.1 Recombinant Human Glial Maturation Factor Beta (GMFb) Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Recombinant Human Glial Maturation Factor Beta (GMFb)
8.4 Recombinant Human Glial Maturation Factor Beta (GMFb) Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Recombinant Human Glial Maturation Factor Beta (GMFb) Distributors List
9.3 Recombinant Human Glial Maturation Factor Beta (GMFb) Customers
10 Recombinant Human Glial Maturation Factor Beta (GMFb) Market Dynamics
10.1 Recombinant Human Glial Maturation Factor Beta (GMFb) Industry Trends
10.2 Recombinant Human Glial Maturation Factor Beta (GMFb) Market Drivers
10.3 Recombinant Human Glial Maturation Factor Beta (GMFb) Market Challenges
10.4 Recombinant Human Glial Maturation Factor Beta (GMFb) Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Recombinant Human Glial Maturation Factor Beta (GMFb) Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Recombinant Human Glial Maturation Factor Beta (GMFb) Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Recombinant Human Glial Maturation Factor Beta (GMFb) Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Recombinant Human Glial Maturation Factor Beta (GMFb) Sales (K Units) by Region (2020-2025)
Table 5. Global Recombinant Human Glial Maturation Factor Beta (GMFb) Sales Market Share by Region (2020-2025)
Table 6. Global Recombinant Human Glial Maturation Factor Beta (GMFb) Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Recombinant Human Glial Maturation Factor Beta (GMFb) Revenue Share by Region (2020-2025)
Table 8. Global Recombinant Human Glial Maturation Factor Beta (GMFb) Sales (K Units) Forecast by Region (2026-2031)
Table 9. Global Recombinant Human Glial Maturation Factor Beta (GMFb) Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Recombinant Human Glial Maturation Factor Beta (GMFb) Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Recombinant Human Glial Maturation Factor Beta (GMFb) Revenue Share Forecast by Region (2026-2031)
Table 12. Global Recombinant Human Glial Maturation Factor Beta (GMFb) Sales by Type (K Units) & (2020-2025)
Table 13. Global Recombinant Human Glial Maturation Factor Beta (GMFb) Sales Share by Type (2020-2025)
Table 14. Global Recombinant Human Glial Maturation Factor Beta (GMFb) Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Recombinant Human Glial Maturation Factor Beta (GMFb) Price by Type (US$/Unit) & (2020-2025)
Table 16. Global Recombinant Human Glial Maturation Factor Beta (GMFb) Sales by Type (K Units) & (2026-2031)
Table 17. Global Recombinant Human Glial Maturation Factor Beta (GMFb) Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Recombinant Human Glial Maturation Factor Beta (GMFb) Price by Type (US$/Unit) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Recombinant Human Glial Maturation Factor Beta (GMFb) Sales by Application (K Units) & (2020-2025)
Table 21. Global Recombinant Human Glial Maturation Factor Beta (GMFb) Sales Share by Application (2020-2025)
Table 22. Global Recombinant Human Glial Maturation Factor Beta (GMFb) Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Recombinant Human Glial Maturation Factor Beta (GMFb) Price by Application (US$/Unit) & (2020-2025)
Table 24. Global Recombinant Human Glial Maturation Factor Beta (GMFb) Sales by Application (K Units) & (2026-2031)
Table 25. Global Recombinant Human Glial Maturation Factor Beta (GMFb) Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Recombinant Human Glial Maturation Factor Beta (GMFb) Price by Application (US$/Unit) & (2026-2031)
Table 27. New Sources of Growth in Recombinant Human Glial Maturation Factor Beta (GMFb) Application
Table 28. Global Recombinant Human Glial Maturation Factor Beta (GMFb) Sales by Company (K Units) & (2020-2025)
Table 29. Global Recombinant Human Glial Maturation Factor Beta (GMFb) Sales Share by Company (2020-2025)
Table 30. Global Recombinant Human Glial Maturation Factor Beta (GMFb) Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Recombinant Human Glial Maturation Factor Beta (GMFb) Revenue Share by Company (2020-2025)
Table 32. Global Recombinant Human Glial Maturation Factor Beta (GMFb) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human Glial Maturation Factor Beta (GMFb) as of 2024)
Table 33. Global Market Recombinant Human Glial Maturation Factor Beta (GMFb) Average Price by Company (US$/Unit) & (2020-2025)
Table 34. Global Key Manufacturers of Recombinant Human Glial Maturation Factor Beta (GMFb), Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Recombinant Human Glial Maturation Factor Beta (GMFb), Product Type & Application
Table 36. Global Key Manufacturers of Recombinant Human Glial Maturation Factor Beta (GMFb), Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Recombinant Human Glial Maturation Factor Beta (GMFb) Sales by Company (2020-2025) & (K Units)
Table 39. North America Recombinant Human Glial Maturation Factor Beta (GMFb) Sales Market Share by Company (2020-2025)
Table 40. North America Recombinant Human Glial Maturation Factor Beta (GMFb) Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Recombinant Human Glial Maturation Factor Beta (GMFb) Revenue Market Share by Company (2020-2025)
Table 42. North America Recombinant Human Glial Maturation Factor Beta (GMFb) Sales by Type (2020-2025) & (K Units)
Table 43. North America Recombinant Human Glial Maturation Factor Beta (GMFb) Sales Market Share by Type (2020-2025)
Table 44. North America Recombinant Human Glial Maturation Factor Beta (GMFb) Sales by Application (2020-2025) & (K Units)
Table 45. North America Recombinant Human Glial Maturation Factor Beta (GMFb) Sales Market Share by Application (2020-2025)
Table 46. Europe Recombinant Human Glial Maturation Factor Beta (GMFb) Sales by Company (2020-2025) & (K Units)
Table 47. Europe Recombinant Human Glial Maturation Factor Beta (GMFb) Sales Market Share by Company (2020-2025)
Table 48. Europe Recombinant Human Glial Maturation Factor Beta (GMFb) Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Recombinant Human Glial Maturation Factor Beta (GMFb) Revenue Market Share by Company (2020-2025)
Table 50. Europe Recombinant Human Glial Maturation Factor Beta (GMFb) Sales by Type (2020-2025) & (K Units)
Table 51. Europe Recombinant Human Glial Maturation Factor Beta (GMFb) Sales Market Share by Type (2020-2025)
Table 52. Europe Recombinant Human Glial Maturation Factor Beta (GMFb) Sales by Application (2020-2025) & (K Units)
Table 53. Europe Recombinant Human Glial Maturation Factor Beta (GMFb) Sales Market Share by Application (2020-2025)
Table 54. China Recombinant Human Glial Maturation Factor Beta (GMFb) Sales by Company (2020-2025) & (K Units)
Table 55. China Recombinant Human Glial Maturation Factor Beta (GMFb) Sales Market Share by Company (2020-2025)
Table 56. China Recombinant Human Glial Maturation Factor Beta (GMFb) Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Recombinant Human Glial Maturation Factor Beta (GMFb) Revenue Market Share by Company (2020-2025)
Table 58. China Recombinant Human Glial Maturation Factor Beta (GMFb) Sales by Type (2020-2025) & (K Units)
Table 59. China Recombinant Human Glial Maturation Factor Beta (GMFb) Sales Market Share by Type (2020-2025)
Table 60. China Recombinant Human Glial Maturation Factor Beta (GMFb) Sales by Application (2020-2025) & (K Units)
Table 61. China Recombinant Human Glial Maturation Factor Beta (GMFb) Sales Market Share by Application (2020-2025)
Table 62. Japan Recombinant Human Glial Maturation Factor Beta (GMFb) Sales by Company (2020-2025) & (K Units)
Table 63. Japan Recombinant Human Glial Maturation Factor Beta (GMFb) Sales Market Share by Company (2020-2025)
Table 64. Japan Recombinant Human Glial Maturation Factor Beta (GMFb) Revenue by Company (2020-2025) & (US$ Million)
Table 65. Japan Recombinant Human Glial Maturation Factor Beta (GMFb) Revenue Market Share by Company (2020-2025)
Table 66. Japan Recombinant Human Glial Maturation Factor Beta (GMFb) Sales by Type (2020-2025) & (K Units)
Table 67. Japan Recombinant Human Glial Maturation Factor Beta (GMFb) Sales Market Share by Type (2020-2025)
Table 68. Japan Recombinant Human Glial Maturation Factor Beta (GMFb) Sales by Application (2020-2025) & (K Units)
Table 69. Japan Recombinant Human Glial Maturation Factor Beta (GMFb) Sales Market Share by Application (2020-2025)
Table 70. Thermo Fisher Scientific Inc. Company Information
Table 71. Thermo Fisher Scientific Inc. Description and Business Overview
Table 72. Thermo Fisher Scientific Inc. Recombinant Human Glial Maturation Factor Beta (GMFb) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Thermo Fisher Scientific Inc. Recombinant Human Glial Maturation Factor Beta (GMFb) Product
Table 74. Thermo Fisher Scientific Inc. Recent Development
Table 75. Bio-Techne Company Information
Table 76. Bio-Techne Description and Business Overview
Table 77. Bio-Techne Recombinant Human Glial Maturation Factor Beta (GMFb) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Bio-Techne Recombinant Human Glial Maturation Factor Beta (GMFb) Product
Table 79. Bio-Techne Recent Development
Table 80. Scientists Helping Scientists Company Information
Table 81. Scientists Helping Scientists Description and Business Overview
Table 82. Scientists Helping Scientists Recombinant Human Glial Maturation Factor Beta (GMFb) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Scientists Helping Scientists Recombinant Human Glial Maturation Factor Beta (GMFb) Product
Table 84. Scientists Helping Scientists Recent Development
Table 85. Abcam Limited Company Information
Table 86. Abcam Limited Description and Business Overview
Table 87. Abcam Limited Recombinant Human Glial Maturation Factor Beta (GMFb) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Abcam Limited Recombinant Human Glial Maturation Factor Beta (GMFb) Product
Table 89. Abcam Limited Recent Development
Table 90. FUJIFILM Irvine Scientific Company Information
Table 91. FUJIFILM Irvine Scientific Description and Business Overview
Table 92. FUJIFILM Irvine Scientific Recombinant Human Glial Maturation Factor Beta (GMFb) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. FUJIFILM Irvine Scientific Recombinant Human Glial Maturation Factor Beta (GMFb) Product
Table 94. FUJIFILM Irvine Scientific Recent Development
Table 95. BD Biosciences Company Information
Table 96. BD Biosciences Description and Business Overview
Table 97. BD Biosciences Recombinant Human Glial Maturation Factor Beta (GMFb) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. BD Biosciences Recombinant Human Glial Maturation Factor Beta (GMFb) Product
Table 99. BD Biosciences Recent Development
Table 100. Bio-Rad Laboratories, Inc. Company Information
Table 101. Bio-Rad Laboratories, Inc. Description and Business Overview
Table 102. Bio-Rad Laboratories, Inc. Recombinant Human Glial Maturation Factor Beta (GMFb) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Bio-Rad Laboratories, Inc. Recombinant Human Glial Maturation Factor Beta (GMFb) Product
Table 104. Bio-Rad Laboratories, Inc. Recent Development
Table 105. BPS Bioscience, Inc. Company Information
Table 106. BPS Bioscience, Inc. Description and Business Overview
Table 107. BPS Bioscience, Inc. Recombinant Human Glial Maturation Factor Beta (GMFb) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. BPS Bioscience, Inc. Recombinant Human Glial Maturation Factor Beta (GMFb) Product
Table 109. BPS Bioscience, Inc. Recent Development
Table 110. Elabscience Company Information
Table 111. Elabscience Description and Business Overview
Table 112. Elabscience Recombinant Human Glial Maturation Factor Beta (GMFb) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Elabscience Recombinant Human Glial Maturation Factor Beta (GMFb) Product
Table 114. Elabscience Recent Development
Table 115. Yisheng Biotechnology (Shanghai) Co., Ltd. Company Information
Table 116. Yisheng Biotechnology (Shanghai) Co., Ltd. Description and Business Overview
Table 117. Yisheng Biotechnology (Shanghai) Co., Ltd. Recombinant Human Glial Maturation Factor Beta (GMFb) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Yisheng Biotechnology (Shanghai) Co., Ltd. Recombinant Human Glial Maturation Factor Beta (GMFb) Product
Table 119. Yisheng Biotechnology (Shanghai) Co., Ltd. Recent Development
Table 120. Abbkine Company Information
Table 121. Abbkine Description and Business Overview
Table 122. Abbkine Recombinant Human Glial Maturation Factor Beta (GMFb) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Abbkine Recombinant Human Glial Maturation Factor Beta (GMFb) Product
Table 124. Abbkine Recent Development
Table 125. Beijing Biocreative Technology Co., Ltd. Company Information
Table 126. Beijing Biocreative Technology Co., Ltd. Description and Business Overview
Table 127. Beijing Biocreative Technology Co., Ltd. Recombinant Human Glial Maturation Factor Beta (GMFb) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Beijing Biocreative Technology Co., Ltd. Recombinant Human Glial Maturation Factor Beta (GMFb) Product
Table 129. Beijing Biocreative Technology Co., Ltd. Recent Development
Table 130. Shanghai Yaji Biotechnology Co., Ltd. Company Information
Table 131. Shanghai Yaji Biotechnology Co., Ltd. Description and Business Overview
Table 132. Shanghai Yaji Biotechnology Co., Ltd. Recombinant Human Glial Maturation Factor Beta (GMFb) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Shanghai Yaji Biotechnology Co., Ltd. Recombinant Human Glial Maturation Factor Beta (GMFb) Product
Table 134. Shanghai Yaji Biotechnology Co., Ltd. Recent Development
Table 135. Cellverse Co., Ltd. Company Information
Table 136. Cellverse Co., Ltd. Description and Business Overview
Table 137. Cellverse Co., Ltd. Recombinant Human Glial Maturation Factor Beta (GMFb) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Cellverse Co., Ltd. Recombinant Human Glial Maturation Factor Beta (GMFb) Product
Table 139. Cellverse Co., Ltd. Recent Development
Table 140. Dalian Meilun Biotech Co., Ltd. Company Information
Table 141. Dalian Meilun Biotech Co., Ltd. Description and Business Overview
Table 142. Dalian Meilun Biotech Co., Ltd. Recombinant Human Glial Maturation Factor Beta (GMFb) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Dalian Meilun Biotech Co., Ltd. Recombinant Human Glial Maturation Factor Beta (GMFb) Product
Table 144. Dalian Meilun Biotech Co., Ltd. Recent Development
Table 145. Sino Biological,Inc. Company Information
Table 146. Sino Biological,Inc. Description and Business Overview
Table 147. Sino Biological,Inc. Recombinant Human Glial Maturation Factor Beta (GMFb) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Sino Biological,Inc. Recombinant Human Glial Maturation Factor Beta (GMFb) Product
Table 149. Sino Biological,Inc. Recent Development
Table 150. Prospec-Tany Technogene Ltd Company Information
Table 151. Prospec-Tany Technogene Ltd Description and Business Overview
Table 152. Prospec-Tany Technogene Ltd Recombinant Human Glial Maturation Factor Beta (GMFb) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Prospec-Tany Technogene Ltd Recombinant Human Glial Maturation Factor Beta (GMFb) Product
Table 154. Prospec-Tany Technogene Ltd Recent Development
Table 155. ENZO Company Information
Table 156. ENZO Description and Business Overview
Table 157. ENZO Recombinant Human Glial Maturation Factor Beta (GMFb) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 158. ENZO Recombinant Human Glial Maturation Factor Beta (GMFb) Product
Table 159. ENZO Recent Development
Table 160. Production Base and Market Concentration Rate of Raw Material
Table 161. Key Suppliers of Raw Materials
Table 162. Recombinant Human Glial Maturation Factor Beta (GMFb) Distributors List
Table 163. Recombinant Human Glial Maturation Factor Beta (GMFb) Customers List
Table 164. Recombinant Human Glial Maturation Factor Beta (GMFb) Market Trends
Table 165. Recombinant Human Glial Maturation Factor Beta (GMFb) Market Drivers
Table 166. Recombinant Human Glial Maturation Factor Beta (GMFb) Market Challenges
Table 167. Recombinant Human Glial Maturation Factor Beta (GMFb) Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Recombinant Human Glial Maturation Factor Beta (GMFb) Product Picture
Figure 2. Global Recombinant Human Glial Maturation Factor Beta (GMFb) Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Recombinant Human Glial Maturation Factor Beta (GMFb) Sales Market Share by Type in 2024 & 2031
Figure 4. Purity＜95% Product Picture
Figure 5. Purity ≥95% Product Picture
Figure 6. Global Recombinant Human Glial Maturation Factor Beta (GMFb) Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 7. Global Recombinant Human Glial Maturation Factor Beta (GMFb) Sales Market Share by Application in 2024 & 2031
Figure 8. University Examples
Figure 9. Research Center Examples
Figure 10. Global Recombinant Human Glial Maturation Factor Beta (GMFb) Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Recombinant Human Glial Maturation Factor Beta (GMFb) Sales Growth Rate (2020-2031) & (US$ Million)
Figure 12. Global Recombinant Human Glial Maturation Factor Beta (GMFb) Sales (K Units) Growth Rate (2020-2031)
Figure 13. Global Recombinant Human Glial Maturation Factor Beta (GMFb) Price Trends Growth Rate (2020-2031) & (US$/Unit)
Figure 14. Recombinant Human Glial Maturation Factor Beta (GMFb) Report Years Considered
Figure 15. Global Market Recombinant Human Glial Maturation Factor Beta (GMFb) Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 16. Global Recombinant Human Glial Maturation Factor Beta (GMFb) Revenue Market Share by Region: 2020 VS 2024
Figure 17. North America Recombinant Human Glial Maturation Factor Beta (GMFb) Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. North America Recombinant Human Glial Maturation Factor Beta (GMFb) Sales (K Units) Growth Rate (2020-2031)
Figure 19. Europe Recombinant Human Glial Maturation Factor Beta (GMFb) Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. Europe Recombinant Human Glial Maturation Factor Beta (GMFb) Sales (K Units) Growth Rate (2020-2031)
Figure 21. China Recombinant Human Glial Maturation Factor Beta (GMFb) Revenue (US$ Million) Growth Rate (2020-2031)
Figure 22. China Recombinant Human Glial Maturation Factor Beta (GMFb) Sales (K Units) Growth Rate (2020-2031)
Figure 23. Japan Recombinant Human Glial Maturation Factor Beta (GMFb) Revenue (US$ Million) Growth Rate (2020-2031)
Figure 24. Japan Recombinant Human Glial Maturation Factor Beta (GMFb) Sales (K Units) Growth Rate (2020-2031)
Figure 25. Global Recombinant Human Glial Maturation Factor Beta (GMFb) Revenue Share by Type (2020-2025)
Figure 26. Global Recombinant Human Glial Maturation Factor Beta (GMFb) Sales Share by Type (2026-2031)
Figure 27. Global Recombinant Human Glial Maturation Factor Beta (GMFb) Revenue Share by Type (2026-2031)
Figure 28. Global Recombinant Human Glial Maturation Factor Beta (GMFb) Revenue Share by Application (2020-2025)
Figure 29. Global Recombinant Human Glial Maturation Factor Beta (GMFb) Revenue Growth Rate by Application in 2020 & 2024
Figure 30. Global Recombinant Human Glial Maturation Factor Beta (GMFb) Sales Share by Application (2026-2031)
Figure 31. Global Recombinant Human Glial Maturation Factor Beta (GMFb) Revenue Share by Application (2026-2031)
Figure 32. Global Recombinant Human Glial Maturation Factor Beta (GMFb) Sales Share by Company (2024)
Figure 33. Global Recombinant Human Glial Maturation Factor Beta (GMFb) Revenue Share by Company (2024)
Figure 34. Global 5 Largest Recombinant Human Glial Maturation Factor Beta (GMFb) Players Market Share by Revenue in Recombinant Human Glial Maturation Factor Beta (GMFb): 2020 & 2024
Figure 35. Recombinant Human Glial Maturation Factor Beta (GMFb) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 36. Manufacturing Cost Structure of Recombinant Human Glial Maturation Factor Beta (GMFb)
Figure 37. Manufacturing Process Analysis of Recombinant Human Glial Maturation Factor Beta (GMFb)
Figure 38. Recombinant Human Glial Maturation Factor Beta (GMFb) Industrial Chain
Figure 39. Channels of Distribution (Direct Vs Distribution)
Figure 40. Distributors Profiles
Figure 41. Bottom-up and Top-down Approaches for This Report
Figure 42. Data Triangulation
Figure 43. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which region is expected to have the highest market share?
For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 6.5% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.
Which companies rank high in the global Recombinant Human Glial Maturation Factor Beta (GMFb) market?
What was the global market size of Recombinant Human Glial Maturation Factor Beta (GMFb) in 2025?
What is the annual compound growth rate of the global Recombinant Human Glial Maturation Factor Beta (GMFb) market size from 2025 to 2031?
What was the global market size of Recombinant Human Glial Maturation Factor Beta (GMFb) in 2031?
Related Reports
Global Recombinant Human Glial Maturation Factor Beta (GMFb) Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Recombinant Human Glial Maturation Factor Beta (GMFb) market is projected to grow from US$ 109 million in 2025 to US$ 168 million by 2032, at a CAGR of 6.5% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-11
Pages: 175
USD 4900.00
(Single User License)
Global Recombinant Human Glial Maturation Factor Beta (GMFb) Market Research Report 2026
The global Recombinant Human Glial Maturation Factor Beta (GMFb) market was valued at US$ 109 million in 2025 and is anticipated to reach US$ 168 million by 2032, at a CAGR of 6.5% from 2026 to 2032.
Published Date: 2026-03-11
Pages: 128
USD 2900.00
(Single User License)
Global Recombinant Human Glial Maturation Factor Beta (GMFb) Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Recombinant Human Glial Maturation Factor Beta (GMFb) market size was US$ 109 million in 2025 and is forecast to reach a readjusted size of US$ 168 million by 2032 with a CAGR of 6.5% during the forecast period 2026-2032.
Published Date: 2026-03-11
Pages: 104
USD 4250.00
(Single User License)
Recombinant Human Glial Maturation Factor Beta (GMFb)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Recombinant Human Glial Maturation Factor Beta (GMFb) was estimated to be worth US$ 109 million in 2025 and is projected to reach US$ 168 million, growing at a CAGR of 6.5% from 2026 to 2032.
Published Date: 2026-03-09
Pages: 136
USD 3950.00
(Single User License)
Global Recombinant Human Glial Maturation Factor Beta (GMFb) Market Research Report 2025
The global market for Recombinant Human Glial Maturation Factor Beta (GMFb) was valued at US$ 104 million in the year 2024 and is projected to reach a revised size of US$ 159 million by 2031, growing at a CAGR of 6.5% during the forecast period.
Published Date: 2025-05-10
Pages: 100
USD 2900.00
(Single User License)
Recombinant Human Glial Maturation Factor Beta (GMFb) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Recombinant Human Glial Maturation Factor Beta (GMFb) was estimated to be worth US$ 104 million in 2024 and is forecast to a readjusted size of US$ 159 million by 2031 with a CAGR of 6.5% during the forecast period 2025-2031.
Published Date: 2025-05-10
Pages: 149
USD 3950.00
(Single User License)
Global Recombinant Human Glial Maturation Factor Beta (GMFb) Market Insights, Forecast to 2031
The global Recombinant Human Glial Maturation Factor Beta (GMFb) market is projected to grow from US$ 109 million in 2025 to US$ 159 million by 2031, at a Compound Annual Growth Rate (CAGR) of 6.5% during the forecast period.
Published Date: 2025-05-10
Pages: 171
USD 4900.00
(Single User License)
Global Recombinant Human Glial Maturation Factor Beta (GMFb) Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Recombinant Human Glial Maturation Factor Beta (GMFb) market is projected to grow from US$ 109 million in 2025 to US$ 168 million by 2032, at a CAGR of 6.5% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-11
Pages: 175
USD 4900.00 (Single User License)Global Recombinant Human Glial Maturation Factor Beta (GMFb) Market Research Report 2026
The global Recombinant Human Glial Maturation Factor Beta (GMFb) market was valued at US$ 109 million in 2025 and is anticipated to reach US$ 168 million by 2032, at a CAGR of 6.5% from 2026 to 2032.
Published: 2026-03-11
Pages: 128
USD 2900.00 (Single User License)Global Recombinant Human Glial Maturation Factor Beta (GMFb) Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Recombinant Human Glial Maturation Factor Beta (GMFb) market size was US$ 109 million in 2025 and is forecast to reach a readjusted size of US$ 168 million by 2032 with a CAGR of 6.5% during the forecast period 2026-2032.
Published: 2026-03-11
Pages: 104
USD 4250.00 (Single User License)Recombinant Human Glial Maturation Factor Beta (GMFb)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Recombinant Human Glial Maturation Factor Beta (GMFb) was estimated to be worth US$ 109 million in 2025 and is projected to reach US$ 168 million, growing at a CAGR of 6.5% from 2026 to 2032.
Published: 2026-03-09
Pages: 136
USD 3950.00 (Single User License)Global Recombinant Human Glial Maturation Factor Beta (GMFb) Market Research Report 2025
The global market for Recombinant Human Glial Maturation Factor Beta (GMFb) was valued at US$ 104 million in the year 2024 and is projected to reach a revised size of US$ 159 million by 2031, growing at a CAGR of 6.5% during the forecast period.
Published: 2025-05-10
Pages: 100
USD 2900.00 (Single User License)Recombinant Human Glial Maturation Factor Beta (GMFb) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Recombinant Human Glial Maturation Factor Beta (GMFb) was estimated to be worth US$ 104 million in 2024 and is forecast to a readjusted size of US$ 159 million by 2031 with a CAGR of 6.5% during the forecast period 2025-2031.
Published: 2025-05-10
Pages: 149
USD 3950.00 (Single User License)Global Recombinant Human Glial Maturation Factor Beta (GMFb) Market Insights, Forecast to 2031
The global Recombinant Human Glial Maturation Factor Beta (GMFb) market is projected to grow from US$ 109 million in 2025 to US$ 159 million by 2031, at a Compound Annual Growth Rate (CAGR) of 6.5% during the forecast period.
Published: 2025-05-10
Pages: 171
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4250.00
USD 6375.00
USD 8500.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now